Results of surgical treatment of N2 bronchogenic carcinoma with negative mediastinoscopy;Resultados del tratamiento quirúrgico del carcinoma broncogénico N2 patológico con mediastinoscopia negativa

Archivos de Bronconeumologia

Volumn 36, Issue 7, 2000, Pages 365-370

  Rami Porta, R ^a   Mateu Navarro, M ^a   Gonzalez Pont G ^a   Cuesta Palomero, M ^a  

^a HOSPITAL MÚTUA DE TERRASSA   (Spain)

Author keywords

Clinical staging; Lung cancer; Mediastinoscopy; N2

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; FEMALE; HUMAN; LABORATORY DIAGNOSIS; LUNG CARCINOMA; LUNG TUMOR; MALE; MEDIASTINOSCOPY; MIDDLE AGED; MORTALITY; PATHOLOGY; SURVIVAL RATE;

ADULT; AGED; CARCINOMA, BRONCHOGENIC; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MEDIASTINOSCOPY; MIDDLE AGED; NEOPLASM STAGING; SURVIVAL RATE;

EID: 0034218011     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2896(15)30135-6     Document Type: Article

References (24)

1. a ed.). Nueva York: Wiley-Liss, 1997; 4-14.
2. Pearson FG, Delarue NC, Ilves R, Todd TRJ, Cooper JD. Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung. J Thorac Cardiovasc Surg 1982; 83: 1-11.
3. Grupo Cooperativo de Carcinoma Broncogénico de SEPAR (GCCB-S). Cirugía del carcinoma broncogénico en España. Estudio descriptivo. Arch Bronconeumol 1995; 31: 303-309.
4. Grupo de Trabajo de la SEPAR. Normativa actualizada (1998) sobre diagnóstico y estadificación del carcinoma broncogénico. Arch Bronconeumol 1998: 34: 437-452.
5. Kaplan E, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
6. Cybulsky IJ, Lanza LA, Ryan B, Putman JB Jr, McMurtrey MM, Roth JA. Prognostic significance of computed tomography in resected N2 lung cancer. Ann Thorac Surg 1992; 54: 533-537.
7. Vansteenkiste JF, De Leyn PR, Deneffe GJ. Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases. Ann Thorac Surg 1997; 63: 1441-1450.
8. Yano T, Fukuyama Y, Yokoyama H. Long-term survivors with pN2 non-small cell lung cancer after a complete resection with a systematic mediastinal node dissection. Eur J Cardiothor Surg 1998; 14: 152-155.
9. Sagawa M, Sakurada A, Fujimura S. Five-year survivors with resected pN2 non-small cell lung carcinoma. Cancer 1999; 85: 864-868.
10. Okada M, Tsubota N, Yoshimura M, Miyamoto Y, Matsuoka H. Prognosis of completely resected pN2 non-small cell lung carcinomas: what is the significant node that affects survival? J Thorac Cardiovasc Surg 1999; 118: 270-275.
11. Dillemans B, Deneffe G, Verschkelen J, Decramer M. Value of computed tomography and mediastinoscopy in preoperative evaluation of mediastinal nodes in non-small cell lung cancer. A study of 569 patients. Eur J Cardiothorac Surg 1994; 8: 37-42.
12. Mori K, Yokoi K, Saito Y, Tominaga K, Miyazawa N. Diagnosis of mediastinal lymph node metastases in lung cancer. Jpn J Clin Oncol 1992; 22: 35-40.
13. McLoud TC, Bourgouin PM, Greenberg RW. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992; 182: 319-323.
14. Staples CA, Müller NL, Miller RR, Evans KG, Nelems B. Mediastinal nodes in bronchogenie carcinoma: comparison between CT and mediastinoscopy. Radiology 1988; 167: 367-372.
15. Kerr KM, Lamb D, Wathen CG, Walker WS, Douglas NJ. Pathological assessment of mediastinal lymph nodes in lung cancer: implications for non-invasive mediastinal staging. Thorax 1992; 47: 337-341.
16. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997; 111: 1718-1723.
17. Naruke T, Goya T, Tsuchiya R, Suemasu K. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 1988; 96: 440-447.
18. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111: 1710-1717.
19. Green MR, Kosty MP, Muscato JJ. Nonoperative management of non-small cell lung cancer: the current Cancer and Leukemia Group B experience. Semin Oncol 1994; 21: 60-65.
20. Belani CP, Aisner J. Combined chemotherapy and radiation in locally advanced non-small cell lung cancer. Semin Oncol 1994; 21: 79-90.
21. Lee JS, Komaki R, Fossella PV. Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small cell lung cancer: Radiation Therapy Oncology Group protocol 91-06. J Clin Oncol 1996; 14: 1055-1064.
22. Rosell R, Gómez-Codina J, Camps C. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med 1994; 330: 153-158.
23. Roth JA, Fossella F, Komaki R et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage III-A non-small-cell lung cancer. J Natl Cancer Inst 1994; 86: 673-680.
24. Rami Porta R, Mateu Navarro M. Video-mediastinoscopy: an improved technique with great teaching potential. The Jubilee 10th World Congress for Bronchology & 10th World Congress for Bronchoesophagology. Budapest: 14-17 de junio de 1998; resumen 164.